RxDoctor Payments Data

Sanjiv Narayan, MD

Clinical Cardiac Electrophysiology · Stanford, CANPI 1649215492

Payments from drug & device makers

What this record shows

The money is spread across several categories — other (53.4%), ownership interests and consulting fees — rather than concentrated in one kind of arrangement. Topera, Inc. accounts for 94.5% of it on its own, with 6 other manufacturers making up the rest. Reporting peaked in 2021 at $190,504 and has fallen 98.0% since, to $3,855 in 2025. Among clinical cardiac electrophysiology clinicians in CA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$356,747in general payments, 2019–2025

Across 17 payments — averaging $20,985 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Topera, Inc.$337K
  • Medical Device Business Services, Inc.$15K
  • Biotronik Inc.$4K
  • Abbott$573
  • Biosense Webster, Inc.$127
  • Elutia, Inc.$104
  • plus $80 from 1 others

What the payments were for

  • Consulting fees$9,1253%
  • Speaking & faculty fees$3,7501%
  • Travel & lodging$5,7362%
  • Food & beverage$9780%
  • Ownership interest$146,75841%
  • Other$190,40053%

General payments by program year

19
20
21
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$356,747 in reported general payments places this provider in the 95th percentile of 290 clinical cardiac electrophysiology providers in California.

See all clinical cardiac electrophysiology providers in California

Medicare billing

Part B allowed, 2024
$33,174
Medicare patients
443
Services billed
539

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban38$48,409
XareltoRivaroxaban12$16,826
MultaqDronedarone Hcl11$15,653
Dofetilide18$2,453

Paid to pharmacies, not to this prescriber.

Other clinical cardiac electrophysiology in Stanford

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →